Everis Medical

Everis Medical operates as a specialized acquirer and developer of niche medical devices, with a core portfolio centered on otolaryngology (ENT) and adjacent surgical specialties. The company commercializes a range of products including the Shaw Scalpel for hemostatic cutting, Biodesign tissue repair grafts, and systems for sialendoscopy and transnasal esophagoscopy, alongside the established STIC pressure monitor and T/Pump therapy system. Leveraging over a century of combined industry experience from its team, Everis follows a build-and-buy strategy to identify and scale clinically impactful but commercially underserved medical technologies. Its business model is commercial-stage, generating revenue through the sale of these medical devices to healthcare institutions.

Acquisition and commercial revitalization platform for underserved, established medical devices. The company integrates products based on diverse technologies (biomaterials, thermal energy, micro-endoscopy, pressure monitoring, temperature therapy) and applies specialized commercial, operational, and support expertise to expand their market impact.

Everis competes in focused segments against both large, diversified medtech companies (e.g., Medtronic, Stryker) that have broader ENT portfolios, and smaller, innovative startups. Its competitive advantage lies in deep specialization, superior customer service, and a focus on commercially revitalizing proven products that may be overlooked by larger players. For specific products like the STIC monitor, it holds a strong, established market position.